You just read:

PARI Pharma's Investigational Closed eFlow Nebulizer System Used in Two Successful Phase 3 Clinical Studies Evaluating Sunovion's SUN-101 (glycopyrrolate) in People with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease (COPD)

News provided by

PARI Pharma

07 Jun, 2016, 08:00 ET